1. Home
  2. ARKO vs AURA Comparison

ARKO vs AURA Comparison

Compare ARKO & AURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ARKO Corp.

ARKO

ARKO Corp.

HOLD

Current Price

$8.65

Market Cap

737.0M

Sector

Energy

ML Signal

HOLD

Logo Aura Biosciences Inc.

AURA

Aura Biosciences Inc.

HOLD

Current Price

$6.41

Market Cap

713.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARKO
AURA
Founded
1970
2007
Country
United States
United States
Employees
9748
N/A
Industry
Oil Refining/Marketing
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
737.0M
713.4M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
ARKO
AURA
Price
$8.65
$6.41
Analyst Decision
Buy
Strong Buy
Analyst Count
2
5
Target Price
$7.50
$20.00
AVG Volume (30 Days)
782.1K
448.1K
Earning Date
05-07-2026
05-08-2026
Dividend Yield
1.91%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$12.86
N/A
Revenue Next Year
$1.49
N/A
P/E Ratio
$56.88
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.71
$4.73
52 Week High
$8.68
$9.54

Technical Indicators

Market Signals
Indicator
ARKO
AURA
Relative Strength Index (RSI) 74.89 35.73
Support Level $7.32 $5.81
Resistance Level N/A $6.56
Average True Range (ATR) 0.32 0.34
MACD 0.06 -0.13
Stochastic Oscillator 92.33 19.95

Price Performance

Historical Comparison
ARKO
AURA

About ARKO ARKO Corp.

ARKO Corp owns and operates convenience stores in the United States. Some of its regional store brands include Stop, Admiral, Apple Market, BreadBox, E-Z Mart, fas mart, Li'l Cricket, and Next Door Store. Its retail store offers hot food service, beverages, cigarettes & other tobacco products, candy, salty snacks, grocery, beer, and general merchandise. ARKO operates in four segments: Retail segment, Wholesale segment, fleet fueling segment, and GPM Petroleum segment. It derives the majority of its revenue from retail and wholesale distribution of fuel.

About AURA Aura Biosciences Inc.

Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.

Share on Social Networks: